|
Back to Home » October 2022 News » Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma |
Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma |
October 04, 2022
OKLAHOMA CITY, Oct. 4, 2022 /PRNewswire/ -- Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMC™, today announced the first closing of...
Source URL: https://www.prnewswire.com:443/news-releases/wheeler-bio-announces-initial-closing-of-series-a-round-supporting-new-biologics-drug-substance-gmp-expansion-in-oklahoma-301639709.html
|
|
|
|
